Letter | Published:

ICOS is critical for CD40-mediated antibody class switching

Nature volume 409, pages 102105 (04 January 2001) | Download Citation

Subjects

Abstract

The inducible co-stimulatory molecule (ICOS) is a CD28 homologue implicated in regulating T-cell differentiation1,2,3,4,5. Because co-stimulatory signals are critical for regulating T-cell activation, an understanding of co-stimulatory signals may enable the design of rational therapies for immune-mediated diseases6. According to the two-signal model for T-cell activation, T cells require an antigen-specific signal and a second, co-stimulatory, signal for optimal T-cell activation6. The co-stimulatory signal promotes T-cell proliferation, lymphokine secretion and effector function. The B7–CD28 pathway provides essential signals for T-cell activation, but does not account for all co-stimulation. We have generated mice lacking ICOS (ICOS-/- ) to determine the essential functions of ICOS. Here we report that ICOS-/- mice exhibit profound deficits in immunoglobulin isotype class switching, accompanied by impaired germinal centre formation. Class switching was restored in ICOS-/- mice by CD40 stimulation, showing that ICOS promotes T-cell/B-cell collaboration through the CD40/CD40L pathway.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , & The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol. Rev. 165, 231–247 ( 1998).

  2. 2.

    et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263–266 (1999).

  3. 3.

    et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 13, 95–105 (2000).

  4. 4.

    et al. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4 + T cells. J. Immunol. 165, 5035 –5040 (2000).

  5. 5.

    et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402, 827–832 ( 1999).

  6. 6.

    et al. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur. J. Immunol. 30, 1040–1047 (2000).

  7. 7.

    , & B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFα. Immunity 11, 423 –432 (1999).

  8. 8.

    et al. Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J. Immunol. 164 , 1653–1657 (2000).

  9. 9.

    et al.LICOS, a primordial costimulatory ligand? Curr. Biol. 10, 333–336 ( 2000).

  10. 10.

    et al. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 96, 2808–2813 (2000).

  11. 11.

    et al. Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J. Exp. Med. 192, 53–61 ( 2000).

  12. 12.

    et al. B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. Immunity 6, 303–313 (1997).

  13. 13.

    Germinal centers: form and function. Curr. Opin. Immunol. 10, 245–251 (1998).

  14. 14.

    et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167–178 (1994).

  15. 15.

    et al. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J. Exp. Med. 183, 2129–2142 ( 1996).

  16. 16.

    , , , & Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur. J. Immunol. 24, 1835– 1842 (1994).

  17. 17.

    et al. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25, 596–603 (1995).

  18. 18.

    & The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17, 138–146 (1996).

  19. 19.

    et al. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J. Immunol. 162, 3942–3949 (1999).

  20. 20.

    , , & B7 costimulation is critical for antibody class switching and CD8+ cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus. J. Virol. 74, 203– 208 (2000).

  21. 21.

    et al. Effects of blocking B7-1 and B7-2 interactions during a type 2 in vivo immune response. J. Immunol. 158, 4088–4096 (1997).

  22. 22.

    , , , & Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. J. Immunol. 158, 2713-2722 (1997).

Download references

Acknowledgements

This work was supported by grants from Genetics Institute (to A.H.S.) and the NIH (to A.J.M., R.J.G., G.J.F. and A.H.S.). We thank M. Collins for thoughtful discussions, and L. Du, J. Burgess and B. Chang for technical support.

Author information

Author notes

    • Gordon J. Freeman
    •  & Arlene H. Sharpe

    These authors contributed equally to this work

Affiliations

  1. *Departments of Pathology, Brigham and Women's Hospital and Harvard Medical School, 221 Longwood Avenue, Boston, Massachusetts 02115, USA

    • Alexander J. McAdam
    • , Rebecca J. Greenwald
    • , Michele A. Levin
    •  & Arlene H. Sharpe
  2. †Department of Adult Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA

    • Tatyana Chernova
    • , Nelly Malenkovich
    •  & Gordon J. Freeman
  3. ‡Department of Immunology, Genetics Institute, 87 CambridgePark Drive, Cambridge, Massachusetts 02081, USA

    • Vincent Ling

Authors

  1. Search for Alexander J. McAdam in:

  2. Search for Rebecca J. Greenwald in:

  3. Search for Michele A. Levin in:

  4. Search for Tatyana Chernova in:

  5. Search for Nelly Malenkovich in:

  6. Search for Vincent Ling in:

  7. Search for Gordon J. Freeman in:

  8. Search for Arlene H. Sharpe in:

Corresponding author

Correspondence to Arlene H. Sharpe.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/35051107

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.